{"id":5311,"date":"2022-10-23T15:32:00","date_gmt":"2022-10-23T14:32:00","guid":{"rendered":"https:\/\/catapult.org.uk\/?post_type=case_study&#038;p=5311"},"modified":"2023-08-21T12:28:46","modified_gmt":"2023-08-21T11:28:46","slug":"upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies","status":"publish","type":"case_study","link":"https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/","title":{"rendered":"Upskilling the UK to take full advantage of the potential of cell and gene therapies"},"content":{"rendered":"\n<div style=\"height:54px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:10%\"><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:90%\">\n<h1 class=\"wp-block-heading\">Upskilling the UK to take full advantage of the potential of cell and gene therapies<\/h1>\n\n\n\n<div style=\"height:54px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"968\" height=\"609\" src=\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2021\/11\/CGTC-3.png\" alt=\"\" class=\"wp-image-4359\" srcset=\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2021\/11\/CGTC-3.png 968w, https:\/\/catapult.org.uk\/wp-content\/uploads\/2021\/11\/CGTC-3-300x189.png 300w, https:\/\/catapult.org.uk\/wp-content\/uploads\/2021\/11\/CGTC-3-768x483.png 768w\" sizes=\"auto, (max-width: 968px) 100vw, 968px\" \/><\/figure><\/div>\n\n\n<div style=\"height:0px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div\n  class=\"mt-5 mb-5 blockQuote  position-relative\"\n  style=\"padding-left: 40px;border-left: solid #393D48 10px;\">\n    <svg class=\"pb-3\" width=\"26\" height=\"40\" viewBox=\"0 0 20 17\"\n    style=\"fill-rule:evenodd;clip-rule:evenodd;stroke-linejoin:round;stroke-miterlimit:2;\">\n    <path\n      d=\"M2.173,0l-2.173,7.704l0,8.796l8.15,0l-0,-8.667l-2.415,-0l1.328,-7.833l-4.89,0Zm11.35,0l-2.173,7.704l0,8.796l8.15,0l0,-8.667l-2.415,-0l1.329,-7.833l-4.891,0Z\"\n      style=\"fill:#FE5000;fill-rule:nonzero;\" \/>\n  <\/svg>\n      <p class=\"quoteContent\" style=\"color:black;\">\n    <em>The ATTC network has enabled the UK Cell and Gene Therapy industry to accelerate<br>solutions to Cell and Gene Therapy specific delivery challenges. The network is globally<br>respected and a number of countries look to replicate similar supportive structures.<\/em>  <\/p>\n  \n    <div class=\"quoteFooterContent pt-3 pb-3\"\n    style=\"font-size: 1.125rem; color: black;\">\n    <strong>Kwok Pang<\/strong><br>Chief Operating Officer at Autolomous  <\/div>\n  \n  \n    <div class=\"text-right\">\n    <svg width=\"26\" height=\"40\" viewBox=\"0 0 20 17\"\n      style=\"fill-rule:evenodd;clip-rule:evenodd;stroke-linejoin:round;stroke-miterlimit:2;\">\n      <path\n        d=\"M17.464,16.594l2.19,-7.748l-0,-8.846l-8.214,0l-0,8.716l2.434,0l-1.339,7.878l4.929,-0Zm-11.44,-0l2.19,-7.748l0,-8.846l-8.214,0l0,8.716l2.434,0l-1.339,7.878l4.929,-0Z\"\n        style=\"fill:#FE5000;fill-rule:nonzero;\" \/>\n    <\/svg>\n  <\/div>\n  <\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p>Cell and Gene Therapy Catapult is a global leader in skills in a rapidly growing sector. Through a range of initiatives such as the world\u2019s first apprenticeship programme for cell and gene therapies and a national training network it now supports a sector employing almost 7,000 people from across the UK, with the workforce predicted to grow to over 15,000 by 2026.<\/p>\n\n\n\n<p>The Catapult coordinated the founding of Advanced Therapy Treatment Centres (ATTCs) in 2018. Its purpose was to form partnerships between academia, regulators, hospitals, supply chain experts and therapy manufacturers, to accelerate products out of the laboratory to the bedside, increasing the opportunity for companies to grow and expand.<\/p>\n\n\n\n<p>Today the network comprises more than 800 people from 49 companies, 13 research institutions, seven Government agencies and 25 NHS trusts\/boards. It is supporting 92 ATMP clinical trials within the UK, 5% of the global total. <\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p>The training tools it has developed are widely employed, including a e-learning platform with 73 modules and an on-line \u2018NHS readiness tool\u2019, which has been accessed over 17,500 times.<\/p>\n\n\n\n<p>Overall the ATTC is globally recognised for its excellence in developing processes and infrastructure required to increase patient access to life-changing advanced therapies.<\/p>\n\n\n\n<p>To support the skills and training required for ATMP manufacture, the Catapult has established the world&#8217;s first apprenticeship programme with the Advanced Therapies Apprenticeship Community (ATAC) and the Advanced Therapy Skills Training network (ATSTN) with dedicated ATMP and bioprocessing training facilities on online training tools.<\/p>\n\n\n\n<p>A recent sector survey reveals employment to be well beyond those initial estimates with 6,956 employees in 2021, forecast to more than double to 15,114 by 2026<\/p>\n<\/div>\n<\/div>\n\n\n\n<div style=\"height:0px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div style=\"height:0px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div style=\"background-color: white;background:\"\n                    class=\"pt-5 pb-5  alignwide\"\n                >    <div class=\"container impactGrid\">        <div class=\"row\">            <div class=\"col-md-6 border-top-dashed border-bottom-sm-dashed border-right-sm-dashed pl-0 pr-0 pt-4 pb-4 d-flex align-items-center\"\n                                style=\"border-color:#FE5000;color:#FE5000;\"\n                            >                    <div class=\"col-md-8 d-flex flex-column justify-content-center\">                        <span class=\"figure\"\n                                            style=\"font-size:2.8125rem\"\n                                        >\n                                            92\n                                        <\/span>\n\n                                        <br\/>\n\n                                        <div class=\"raleway font-weight-bold\">\n                                            ATMP clinical trials supported in the UK, 5% of the global total\n                                        <\/div>\n\n                                    <\/div>\n\n                                    <div class=\"col-4 col-sm-2 col-md-4 d-flex justify-content-center\"><img loading=\"lazy\" decoding=\"async\" width=\"70\" height=\"70\" class=\"img-fluid\" style=\"object-fit:contain\" src=\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2020\/12\/globe-solid.svg\">                    <\/div>\n\n                            <\/div>            <div class=\"col-md-6 border-top-dashed border-bottom-dashed pr-0 pl-0 pt-4 pb-4 d-flex align-items-center\"\n                                style=\"border-color:#FE5000;color:#FE5000;\"\n                            >                    <div class=\"col-md-8 d-flex flex-column justify-content-center\">                        <span class=\"figure\"\n                                            style=\"font-size:2.8125rem\"\n                                        >\n                                            6,956\n                                        <\/span>\n\n                                        <br\/>\n\n                                        <div class=\"raleway font-weight-bold\">\n                                            employed in sector, forecast to more than double by  2026 to 15,114\n                                        <\/div>                    <\/div>\n\n                                    <div class=\"col-4 col-sm-2 col-md-4 d-flex justify-content-center\">                            <img loading=\"lazy\" decoding=\"async\" width=\"70\" height=\"70\" class=\"img-fluid\" style=\"object-fit:contain\" src=\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2020\/12\/icons-people.svg\">                    <\/div>\n\n                            <\/div>\n\n                        <\/div>    <\/div>\n\n                <\/div>\n\n\n<div style=\"height:0px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div class=\"wp-block-image is-style-rounded\">\n<figure class=\"aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"552\" height=\"392\" src=\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/CGTC-priority-1-Skills-and-training-1.png\" alt=\"\" class=\"wp-image-5313\" srcset=\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/CGTC-priority-1-Skills-and-training-1.png 552w, https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/CGTC-priority-1-Skills-and-training-1-300x213.png 300w\" sizes=\"auto, (max-width: 552px) 100vw, 552px\" \/><\/figure><\/div>\n\n\n<p><\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:10%\"><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><\/div>\n<\/div>\n\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cell and Gene Therapy Catapult is a global leader in skills in a rapidly growing sector. Through a range of initiatives such as the world\u2019s first apprenticeship programme for cell and gene therapies and a national training network it now supports a sector employing almost 7,000 people from across the UK, with the workforce predicted to grow to over 15,000 by 2026. <\/p>\n","protected":false},"featured_media":5308,"template":"","meta":{"_external_link_checkbox":false,"_external_link":"","_event_date":"","_featured_case_study":false},"categories":[9],"tags":[56,61],"class_list":["post-5311","case_study","type-case_study","status-publish","has-post-thumbnail","hentry","category-cell-and-gene-therapy","tag-skills","tag-catapult-highlights"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Upskilling the UK to take full advantage of the potential of cell and gene therapies - The Catapult Network<\/title>\n<meta name=\"description\" content=\"Cell and Gene Therapy Catapult is a global leader in skills in a rapidly growing sector. Through a range of initiatives such as the world\u2019s first apprenticeship programme for cell and gene therapies and a national training network it now supports a sector employing almost 7,000 people from across the UK, with the workforce predicted to grow to over 15,000 by 2026.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Upskilling the UK to take full advantage of the potential of cell and gene therapies - The Catapult Network\" \/>\n<meta property=\"og:description\" content=\"Cell and Gene Therapy Catapult is a global leader in skills in a rapidly growing sector. Through a range of initiatives such as the world\u2019s first apprenticeship programme for cell and gene therapies and a national training network it now supports a sector employing almost 7,000 people from across the UK, with the workforce predicted to grow to over 15,000 by 2026.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/\" \/>\n<meta property=\"og:site_name\" content=\"The Catapult Network\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-21T11:28:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/CGTC-2-e1681316311632-1024x635.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"635\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Catapult_UK\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/\",\"url\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/\",\"name\":\"Upskilling the UK to take full advantage of the potential of cell and gene therapies - The Catapult Network\",\"isPartOf\":{\"@id\":\"https:\/\/catapult.org.uk\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/CGTC-2-e1681316311632.png\",\"datePublished\":\"2022-10-23T14:32:00+00:00\",\"dateModified\":\"2023-08-21T11:28:46+00:00\",\"description\":\"Cell and Gene Therapy Catapult is a global leader in skills in a rapidly growing sector. Through a range of initiatives such as the world\u2019s first apprenticeship programme for cell and gene therapies and a national training network it now supports a sector employing almost 7,000 people from across the UK, with the workforce predicted to grow to over 15,000 by 2026.\",\"breadcrumb\":{\"@id\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/#primaryimage\",\"url\":\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/CGTC-2-e1681316311632.png\",\"contentUrl\":\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/CGTC-2-e1681316311632.png\",\"width\":1282,\"height\":795},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/catapult.org.uk\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Case Studies\",\"item\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Upskilling the UK to take full advantage of the potential of cell and gene therapies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/catapult.org.uk\/#website\",\"url\":\"https:\/\/catapult.org.uk\/\",\"name\":\"The Catapult Network\",\"description\":\"The Innovate UK Catapult Network\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/catapult.org.uk\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Upskilling the UK to take full advantage of the potential of cell and gene therapies - The Catapult Network","description":"Cell and Gene Therapy Catapult is a global leader in skills in a rapidly growing sector. Through a range of initiatives such as the world\u2019s first apprenticeship programme for cell and gene therapies and a national training network it now supports a sector employing almost 7,000 people from across the UK, with the workforce predicted to grow to over 15,000 by 2026.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/","og_locale":"en_GB","og_type":"article","og_title":"Upskilling the UK to take full advantage of the potential of cell and gene therapies - The Catapult Network","og_description":"Cell and Gene Therapy Catapult is a global leader in skills in a rapidly growing sector. Through a range of initiatives such as the world\u2019s first apprenticeship programme for cell and gene therapies and a national training network it now supports a sector employing almost 7,000 people from across the UK, with the workforce predicted to grow to over 15,000 by 2026.","og_url":"https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/","og_site_name":"The Catapult Network","article_modified_time":"2023-08-21T11:28:46+00:00","og_image":[{"width":1024,"height":635,"url":"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/CGTC-2-e1681316311632-1024x635.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@Catapult_UK","twitter_misc":{"Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/","url":"https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/","name":"Upskilling the UK to take full advantage of the potential of cell and gene therapies - The Catapult Network","isPartOf":{"@id":"https:\/\/catapult.org.uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/#primaryimage"},"image":{"@id":"https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/CGTC-2-e1681316311632.png","datePublished":"2022-10-23T14:32:00+00:00","dateModified":"2023-08-21T11:28:46+00:00","description":"Cell and Gene Therapy Catapult is a global leader in skills in a rapidly growing sector. Through a range of initiatives such as the world\u2019s first apprenticeship programme for cell and gene therapies and a national training network it now supports a sector employing almost 7,000 people from across the UK, with the workforce predicted to grow to over 15,000 by 2026.","breadcrumb":{"@id":"https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/#primaryimage","url":"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/CGTC-2-e1681316311632.png","contentUrl":"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/CGTC-2-e1681316311632.png","width":1282,"height":795},{"@type":"BreadcrumbList","@id":"https:\/\/catapult.org.uk\/our-work\/case-studies\/upskilling-the-uk-to-take-full-advantage-of-the-potential-of-cell-and-gene-therapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/catapult.org.uk\/"},{"@type":"ListItem","position":2,"name":"Case Studies","item":"https:\/\/catapult.org.uk\/our-work\/case-studies\/"},{"@type":"ListItem","position":3,"name":"Upskilling the UK to take full advantage of the potential of cell and gene therapies"}]},{"@type":"WebSite","@id":"https:\/\/catapult.org.uk\/#website","url":"https:\/\/catapult.org.uk\/","name":"The Catapult Network","description":"The Innovate UK Catapult Network","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/catapult.org.uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"}]}},"_links":{"self":[{"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/case_study\/5311","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/case_study"}],"about":[{"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/types\/case_study"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/media\/5308"}],"wp:attachment":[{"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/media?parent=5311"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/categories?post=5311"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/tags?post=5311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}